» Articles » PMID: 37460527

Restoration of PITPNA in Type 2 Diabetic Human Islets Reverses Pancreatic Beta-cell Dysfunction

Abstract

Defects in insulin processing and granule maturation are linked to pancreatic beta-cell failure during type 2 diabetes (T2D). Phosphatidylinositol transfer protein alpha (PITPNA) stimulates activity of phosphatidylinositol (PtdIns) 4-OH kinase to produce sufficient PtdIns-4-phosphate (PtdIns-4-P) in the trans-Golgi network to promote insulin granule maturation. PITPNA in beta-cells of T2D human subjects is markedly reduced suggesting its depletion accompanies beta-cell dysfunction. Conditional deletion of Pitpna in the beta-cells of Ins-Cre, Pitpna mice leads to hyperglycemia resulting from decreasing glucose-stimulated insulin secretion (GSIS) and reducing pancreatic beta-cell mass. Furthermore, PITPNA silencing in human islets confirms its role in PtdIns-4-P synthesis and leads to impaired insulin granule maturation and docking, GSIS, and proinsulin processing with evidence of ER stress. Restoration of PITPNA in islets of T2D human subjects reverses these beta-cell defects and identify PITPNA as a critical target linked to beta-cell failure in T2D.

Citing Articles

NFAT5 exacerbates β-cell ferroptosis by suppressing the transcription of PRDX2 in obese type 2 diabetes mellitus.

Guan G, Liu J, Zhang Q, He M, Liu H, Chen K Cell Mol Life Sci. 2025; 82(1):64.

PMID: 39875646 PMC: 11775373. DOI: 10.1007/s00018-024-05563-y.


Exploring the design of clinical research studies on the efficacy mechanisms in type 2 diabetes mellitus.

Guan H, Zhao S, Li J, Wang Y, Niu P, Zhang Y Front Endocrinol (Lausanne). 2024; 15:1363877.

PMID: 39371930 PMC: 11449758. DOI: 10.3389/fendo.2024.1363877.


Targeting β-Cell Plasticity: A Promising Approach for Diabetes Treatment.

Gojani E, Rai S, Norouzkhani F, Shujat S, Wang B, Li D Curr Issues Mol Biol. 2024; 46(7):7621-7667.

PMID: 39057094 PMC: 11275945. DOI: 10.3390/cimb46070453.


Mammalian START-like phosphatidylinositol transfer proteins - Physiological perspectives and roles in cancer biology.

Pathak A, Willis K, Bankaitis V, McDermott M Biochim Biophys Acta Mol Cell Biol Lipids. 2024; 1869(7):159529.

PMID: 38945251 PMC: 11533902. DOI: 10.1016/j.bbalip.2024.159529.


Loss of the Golgi-localized v-ATPase subunit does not alter insulin granule formation or pancreatic islet β-cell function.

Boyer C, Blom S, Machado A, Rohli K, Maxson M, Stephens S Am J Physiol Endocrinol Metab. 2024; 326(3):E245-E257.

PMID: 38265287 PMC: 11193524. DOI: 10.1152/ajpendo.00342.2023.


References
1.
Martin T . Phosphoinositide lipids as signaling molecules: common themes for signal transduction, cytoskeletal regulation, and membrane trafficking. Annu Rev Cell Dev Biol. 1999; 14:231-64. DOI: 10.1146/annurev.cellbio.14.1.231. View

2.
Song B, Scheuner D, Ron D, Pennathur S, Kaufman R . Chop deletion reduces oxidative stress, improves beta cell function, and promotes cell survival in multiple mouse models of diabetes. J Clin Invest. 2008; 118(10):3378-89. PMC: 2528909. DOI: 10.1172/JCI34587. View

3.
Alejandro E, Gregg B, Blandino-Rosano M, Cras-Meneur C, Bernal-Mizrachi E . Natural history of β-cell adaptation and failure in type 2 diabetes. Mol Aspects Med. 2014; 42:19-41. PMC: 4404183. DOI: 10.1016/j.mam.2014.12.002. View

4.
De la Cruz L, Traynor-Kaplan A, Vivas O, Hille B, Jensen J . Plasma membrane processes are differentially regulated by type I phosphatidylinositol phosphate 5-kinases and RASSF4. J Cell Sci. 2019; 133(2). PMC: 6983711. DOI: 10.1242/jcs.233254. View

5.
Stuart T, Butler A, Hoffman P, Hafemeister C, Papalexi E, Mauck 3rd W . Comprehensive Integration of Single-Cell Data. Cell. 2019; 177(7):1888-1902.e21. PMC: 6687398. DOI: 10.1016/j.cell.2019.05.031. View